The survey, which includes 181 companies from different countries, found that 12 percent feel “very unprepared” to transport a COVID-19 vaccine when one is authorized, and 45 percent of companies that are able to handle subzero temperatures say they have such capabilities across all of their locations.
The air cargo companies’ biggest concern now is the ability to ensure vaccine temperatures are maintained during air transportation, according to the survey. Two vaccines in late-stage testing — one from Moderna and one from Pfizer — use a gene-based technology that requires the shots to be stored at subzero temperatures.
Ten percent of the surveyed companies said they’re unable to handle temperature-controlled shipments at all.
The companies said they need information as early as possible on trade-lanes, product specifications and specific handling, storage and security conditions to properly plan for vaccine transportation.
Find the full survey here.
More articles on supply chain:
171 COVID-19 testing sites ordered shut for failing to meet US standards
Amazon forms partnership to improve temperature-sensitive vaccine distribution
Labs squeezed for staff to meet COVID-19 testing demand
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
